Ashish Khanna to Cost-Benefit Analysis
This is a "connection" page, showing publications Ashish Khanna has written about Cost-Benefit Analysis.
Connection Strength
0.041
-
Lam SW, Barreto EF, Scott R, Kashani KB, Khanna AK, Bauer SR. Cost-effectiveness of second-line vasopressors for the treatment of septic shock. J Crit Care. 2020 02; 55:48-55.
Score: 0.041